Saxena Nishant C
SEC insider (Form 3/4/5 filer). CIK 0002136365. Chief Business Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 11, 2026. Located in NORWOOD, MA.
Companies Saxena Nishant C has filed insider reports for
- Corbus Pharmaceuticals Holdings, Inc. (CRBP): Officer, Chief Business Officer
Saxena Nishant C
CIK: 0002136365
Transaction Breakdown
Open Market Buys (P)3 (75.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 11, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
PurchaseDirect2.6K shares at avg. $9.63$25K - Jun 3, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
PurchaseDirect9K shares at avg. $7.58$68K - Jun 2, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
PurchaseDirect4.5K shares at avg. $7.33$33K - May 21, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
AwardDirect58.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 11, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Purchase | 2,600 | $9.63 | $25,036 | Direct |
| Jun 3, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Purchase | 9,000 | $7.58 | $68,220 | Direct |
| Jun 2, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Purchase | 4,500 | $7.33 | $32,999 | Direct |
| May 21, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Award | 58,300 | - | $0 | Direct |
1-4 of 4 transactions